Dr. Nassiri is a former Associate Dean of Global Health at the Michigan State University (MSU). He also served as MSU director of Institute of International Health. He is currently Professor of Pharmacology and Toxicology, Professor of Family and Community Medicine, and, lecturer in Global Health, Infectious Diseases and Tropical Medicine. He currently works on international public health issues relating to chronic diseases and has expertise in global health. He has made contributions in various fields of medical sciences including clinical investigation and health education. On the basis of his extensive experience and expertise in chronic infectious diseases including HIV/AIDS, TB as well as antimicrobial resistance and human gut microbiome, he developed clinical research programs in Brazil, South Africa, Haiti, Dominican Republic and Mexico. He had served as editorial board member for the journal of HIV and AIDS Review. He is currently on editorial board member for AIDS Patient Care and STDs. Prof. Nassiri has delivered seminar presentations on Tropical Medicine, HIV/AIDS, TB, Global Health and public health interventions in numerous national and international conferences and workshops. He is internationally recognized for his work in the areas of building effective international partnerships particularly in global health, community health, clinical care capacity building, and technical assistance mechanism. He is the founder of Michigan State University Osteopathic and Primary Health Clinic in Merida, Yucatan, Mexico. He has developed academic and research partnership programs with Federal University of Para Institute of Tropical Medicine in Belem, Brazil.

His research interests are Clinical Pharmacology of HIV/AIDS & TB, human gut microbiome, antibiotic resistance, prevention and control of infectious diseases, neglected tropical diseases, community health, global health, socio-ethical determinants of health, and community-based public health interventions. In collaboration with his Brazilian colleagues, he conducts research in the eastern Brazilian Amazon population on incidence and prevalence of HIV, TB, Hepatitis C, HPV, and antimicrobial resistance.

Dr. Qingzhong Kong graduated with B.S. and M.S degrees in Biochemistry at Nanjing University, China, in 1987 and 1990, respectively. In 1996, he completed a Ph.D. in Molecular Virology at the University of Massachusetts. From 1996 to 2000, he was a Research Associate in Molecular Immunology at Yale University, after which he joined the Department of Pathology at Case Western Reserve University as an assistant professor. Dr. Kong is currently a tenured Associate Professor of Pathology at Case Western Reserve University, where he also holds secondary appointments at the Department of Neurology and the National Center for Regenerative Medicine.

His laboratory focuses on prion diseases, functions of cellular prion protein, and muscle stem cells, including four main research areas: (1) etiology of sporadic Creutzfeldt-Jacob disease (CJD) in humans; (2) public health risks of animal prions (Chronic Wasting Disease of elk and deer, atypical Bovine Spongiform Encephalopathy of cattle, and Transmissible Mink Encephalopathy) and animal modeling of various human prion diseases (especially CJD); (3) the roles of the normal cellular prion protein in the biology and pathology of skeletal muscles and brain; and (4) muscle stem cells. His lab has created dozens of transgenic mouse lines for the above research areas, some of which are inducible by doxycycline or conditional when used with Cre recombinase expressing mice.

Yiping Li, Ph.D., Professor of Molecular Virology, Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-sen University (SYSU), Guangzhou, China. Dr. Yiping Li received Ph.D. degree in Biochemistry and Molecular Biology from China Agricultural University, Beijing, China. From 2003 to 2004 and 2006 to 2007, Dr. Li worked as a visiting scholar, project researcher, and postdoctoral researcher in the National Veterinary Institute, Technical University of Denmark (previous Royal Danish Veterinary Institute). In 2005, Dr. Li pursued hepatitis C virus (HCV) research in the Vaccine and Infectious Disease Organization (VIDO), University of Saskatchewan, Canada. To continue HCV research, in February 2008 Dr. Li joined the Copenhagen Hepatitis C Program (CO-HEP), Hvidovre Hospital and Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. After trainings as a postdoc and senior investigator, Dr. Li took a professor position in Zhongshan School of Medicine, SYSU in January 2014

Dr. Yiping Li’s research interests are in the infection and immunity of HCV. To HCV research, Dr. Li has made important contributions, which have included the discoveries on the host RNA insertion-mediated viral resistance to antiviral effect of miR-122 antagonism, the development of novel full-length infectious culture systems for HCV genotypes 1a, 2a and 2b, as well as chimeric culture systems for HCV genotypes 3a, 4a, 5a, and 6a. Dr. Li’s works have led to publications on well-known journals, such as PNAS, Gastroenterology, Hepatology, PLoS Pathogens, Virology. In addition, Dr. Li also worked on animal viruses and Campylobacter. Dr. Li’s research activities have produced 25 publications, 3 U.S. patent applications and 21 conference abstracts; these have included 12 first author publications (served also as corresponding author in 3 publications) and 5 oral presentations out of 13 first author abstracts in outstanding conferences.

María José Figueras is a researcher at the Department of Basic Medical Sciences of the URV, and a state ambassador for the American Society of Microbiology (ASM, American Society for Microbiology). The network of ambassadors of the ASM aims to promote knowledge of microbiology through state representatives throughout the world. Dr. Figueras now has the mission of strengthening the relationship between the ASM and the scientific community in Spain, as well as collaborating globally with the more than 70 ambassadors of the entity. The ASM is one of the oldest and largest scientific societies in the world. The entity currently has more than 40,000 members, almost half of whom reside outside the United States. Among its objectives is the improvement of health, the environment and economic well-being, through the development and communication of microbiological sciences. María José Figueras graduated (1979) and PhD (1986) in Biology from the University of Barcelona and specialized in electronic microscopy at the University of Groningen (Netherlands). He has developed his professional career in the Biology and Microbiology Unit of the Faculty of Medicine and Health Sciences of the Rovira i Virgili University, where he has been Professor of Microbiology since 2000. In 2012, he received URV recognition for quality of its research with an impact superior to the world average in the area of Microbiology.

Water related and waterborne infections, Taxonomy and epidemiology of the emerging pathogens Aeromonas and Arcobacter and Taxonomy and epidemiology of the Legionella.

He graduated from the National Autonomous University of Mexico (UNAM, 1985-1989), Assistant Professor of the Department of Veterinary Surgery at UNAM 1989-l993. He is diploma in Surgery and Orthopedics in small species. He is founding President of the Association of Veteran Doctors Specialists in Small Species of Celaya, External Advisor of IDEXX Laboratories, and world leader in diagnostic equipment since 2003. He is currently Director of cirugiaveterinaria.mx National and Latin American Speaker in the area of diagnosis and Surgery. He is author of video books of continuous training in veterinary surgery.

Prevalence of zoonotic diseases in animals.

Dr.R Harihara Prakash is the Principal and Professor at K M Patel Institute of Physiotherapy,Karamsad. He has 18 years of professional experience in clinical as well as academics. He is a Doctorate in Physical Therapy from National University of Medical Sciences, Spain. He was awarded with Rashtriya Vidhya Saraswathi Puraskar Award for his excellent contribution in academics. He was former Dean, Faculty of Physiotherapy, Baba Farid University of Health Sciences, Punjab. He is in the Editorial Board and peer reviewer for some international journals. He is also in the panel of NAAC. He has obtained various skills by certification in the field of neurology, osteopathy, manual therapy from various countries. He has published and presented research papers in various national and international conferences. He is an eminent speaker and an academician.

Physiotherapy in preventive and promotive health.

Dr. Pankaja Raghav is Post graduate (MD) from Aurangabad University and joined D Y Patil Medical College, Pune (1998-2010), she was appointed as Head of the Community medicine Department at ACS Medical College, Chennai (2010 -2012) and now she is working as Professor & Head of the Department of Community medicine & Family medicine at AIIMS, Jodhpur since 2012. She also did postgraduate diploma in hospital & health management (PGDHHM) in 2006 & FAIMER Fellowship in 2013.She has 17 years of post MD teaching & research experience. She has carried out a number of research studies in the fields of nutrition, communicable diseases, non-communicable chronic diseases, child behavior, adolescents, accidents, substance abuse & medical education. She has published over 30 research articles in national and international journals of repute and has been on editorial board for the journals.Awarded the “Most Popular and the Best Teacher” of Padm. D. Y. Patil Medical University in 2008 and University Gold Medal for PGDHHM , IGNOU ,New Delhi; award was given by Vice President of India. She is the life member of many professional bodies to name a few Founder Member and Vice President of Indian Public Health Association, Rajasthan Chapter Member of ‘Consultation Group’ of experts and stakeholders to understand epidemiology of re-emerging H1N1 and other communicable diseases. She is a Member of National Academy of Sciences (India).

Non-communicable diseases, Nutrition and Medical education.

Nito Panganiban, Ph.D., is Professor and Interim Division Chair of Microbiology at the Tulane National Primate Research Center, Chief Scientific Officer at Peptineo, and a member of the Department of Microbiology and Immunology at the Tulane University School of Medicine. Dr. Panganiban received his PhD in Microbiology and Immunology from the University of Washington, where he carried out research on bacteriophage RNA processing in Helen Whiteley's lab. He did two years of postdoctoral work on retrovirus replication in Howard Temin's lab at the McArdle Lab for Cancer Research at the University of Wisconsin before joining the faculty at McArdle. He was then a Professor in the Department of Molecular Genetics and Microbiology at the University of New Mexico Health Sciences Center. He moved to Tulane in 2012. Past work has centered on retrovirus replication including HIV. Dr. Panganiban does research on diverse emerging RNA viruses, with emphasis on pathogenic, zoonotic RNA viruses including members of the bunya- and flavivirus families including Zika virus, Rift Valley Fever, Crimean Congo hemorrhagic fever, and hantaviruses. He is an expert in multiple facets of molecular virology and nonhuman primate models for RNA viruses, vaccines, virus-host interaction, high containment facilities, molecular biology, and genomics. In addition to his academic research and teaching, he is CSO of Peptineo (a biotech firm based in Albuquerque), and has served on numerous NIH, and additional, national committees and panels, and has served as a consultant for biotech and multi-investigator consortia.

Differential gene expression using transcriptome analysis, RNA biology, RNA viruses, emerging viruses, zoonotic viruses, host-pathogen interaction, viruses requiring high containment facilities, genomics

Dr. Montelaro is a Professor in the Department of Microbiology and Molecular Genetics of the University of Pittsburgh School of Medicine with secondary appointments in the Department of Infectious Diseases and Immunology (Graduate School or Public Health) and the Department of Medicine Division of Infectious Diseases. He serves as the Co-Director of the Center for Vaccine Research and the Scientific Director of the Peptide Synthesis Core. He received his PhD in Biochemistry in 1975 from the University of Wisconsin-Madison. His research interest is in viral immunology and vaccine development, especially as related to AIDS, emerging diseases, and biodefense.

The primary focus of the Montelaro lab is to elucidate the intricate interactions between viral pathogens and host immune responses to determine the mechanisms by with host immunity contributes to protection and disease and to serve as a basis for the development of effective vaccines. A particular interest of the lab is to develop effective strategies to overcome the challenge of natural viral antigenic variation that has evolved as a common complication to the development of effective vaccines to important viral diseases, including those related to biodefense and emerging infectious diseases. Systems currently under investigation include HIV-1 and related animal lentiviruses (SHIV, SIV, and EIAV). Studies in these systems include investigation of the nature and role of antigenic variation during infection, the development of novel assays to characterize virus-specific innate, humoral, and cellular immune responses, and the design of engineered immunogens for effective vaccination against variant strains of a particular virus. In addition to these vaccine related studies, the lab also maintains a research program to develop novel de novo antimicrobial peptides (engineered cationic amphipathic peptides, or eCAPs) that can be used to inactivate a diverse spectrum of bacteria or enveloped viruses in a prophylactic or therapeutic treatment modalities.

C. A. Guzman graduated in Medicine and become Board Certified in Medical Bacteriology in Argentina. Later, he graduated as Doctor of Medicine and Surgery and obtained his Doctorate in Microbiological Sciences (University Genoa, Italy). In 1994 he became Head of the Vaccine Group (German Research Centre for Biotechnology, Germany). In 2005 he was appointed Head of the Department of Vaccinology and Applied Microbiology (HZI), becoming later also APL-Professor at the Medical School and Member of the Centre for Individualized Infection Medicine (Hannover). His work was instrumental for developing new adjuvants and antigen delivery systems, leading to more than 200 publications.

Professor Grażyna Rydzewska M.D., PhD serves as a Head of the Department of Internal Medicine and Gastroenterology with IBD Subdivision, Central Clinical Hospital of Ministry of Interior and Administration, Warsaw, Poland. She currently serves also as a Vice-president of the Polish Society of Gastroenterology, and founding member and President of the Polish Pancreatic Club, member of coucil in International Association of Pancreatology and member of the European Pancreatic Club. She is also a professor and Director of Institute of Nursing and Obstetrics in Haculty of Medicine and Health Sciences at Jan Kochanowski University, Kielce. She has founded and currently serves as Editor-in-Chief of Gastroenterology Review, also as Editor-in-Chief of International Journal of Gastroenterology Disorders & Therapy. She is a member of editorial board in many journals in gastroenterology and internal medicine field (Nowa Klinika, Polish Gastroenterology, Medical Studies, Lekarz POZ, Gastroenterologia Praktyczna and others). During 10 years she was as Chief of Polish Medical Advisory Council on Gastroenterology (national consultant) and national representative in European Crohn and Colitis Organisation. Professor Rydzewska serves also as a member of clinical advisory boards at some pharmaceutical companies.

Professor Rydzewska main areas of interest are pancreatology, especialy signal transduction in pancreatic cells, prognosis and treatment of acute pancreatitis, treatment and prognosis in inflammatory bowel disease, and gastrointestinal endoscopy. She has published over 150 articles in peer-reviewed journals and over 10 chapters in medical textbooks.

Irene Wagner-Dobler studied biology in Munich and a PhD on an environmental issue - the vertical migration of planktonic insect larvae in lakes. Then she came as an assistant of the Scientific Director to Braunschweig at the GBF - now the HZI - and rose 1989 in the Department of Microbiology. Since they deal with topics of microbial ecology . Since 2001 Irene Wagner-Dobler is a professor at the University of Braunschweig and forwards since 2004, the working group "Microbial Communication". She has won several international research awards.

To understand the mechanisms behind the bacterial communication in detail. Then we can disrupt this radio and thus prevent the bacteria develop their pathogenic properties.

Carmen Alvarez-Dominguez has completed her Ph.D at the age of 29 years from Universidad Autonoma de Madrid and postdoctoral studies from Washington University School of Medicine on Small GTPases role in Listeria monocytogenes phagocytosis. She is the director of the Group on Genomics, Proteomics and Vaccines at the Research Institute Marqués de Valdecilla (IDIVAL) in Santander, Spain. She has published more than 29 papers in reputed journals and serving as an editorial board member of Microbes and Infection and OMICS. She also is coauthor of the patent: Immunogenic peptides against Listeria and Mycobacterium, antibodies and their uses with reference PCT/ES2007/070144.

Kathleen Hefferon received her PhD from the Department of Medical Biophysics, University of Toronto and continued her post-doctoral studies at Cornell University. Dr. Hefferon has worked on faculty at the Division of Nutritional Sciences at Cornell and has written two books on biopharmaceuticals in plants. She teaches and conducts research at both the University of Toronto and Cornell University. Kathleen has 4 patents, has edited 6 books, and has multiple research publications. Kathleen currently lives with her family near Ithaca NY.

Pietro Mastroeni received a Degree in Medicine and Surgery from the University of Messina, Italy. He moved to the University of Cambridge, UK where he completed his Ph.D before becoming a Research Fellow at Imperial College, University of London UK. He is currently a Reader in Infection and Immunity at the University of Cambridge. He has published more than 100 papers in reputed journals and serves as an editorial board member.

Recent research in his group is focused on the study of pathogenesis and immunity to bacterial infections and on the improvement of strategies to deliver vaccines to the immune system. They concurrently run a number of multidisciplinary integrated research projects. Their past research has defined the role of cytokine networks, antibodies, phagocytes, B-cells and T-cell in host resistance to bacterial infections and has unravelled many bacterial virulence genes that counteract the immune system. This work is still evolving and has already contributed to the generation of new vaccine candidates. Recently, they are focused on understanding how individual bacteria interact with host cells in vivo and how subpopulations of microbes spread and distribute in the body. This has been achieved by novel multidisciplinary research approaches that integrate information acquired at different levels spanning from individual cells to global systems. This work has opened the possibility to comprehensively study the mechanistic bases of immune control of bacterial infections, thus opening the field to novel high impact research on improved prevention measures and medical treatments to fight infection. And currently, also delving into the interactions between the host and bacterial genome highlighting which bacterial genes play a role in counteracting specific host mechanisms. This research will lead to the identification of novel targets for vaccines and drug development. We are also exploring other new areas within infection such as the interplay between microbes and autoimmune diseases and the possibility to use recombinant bacteria as anti-cancer agents. This research may have translational outcomes in the generation of tools to modulate the course of autoimmune diseases and to destroy cancer cells in vivo. Another crucial line of research that we are actively pursuing deals with the understanding of how different cellular population and cell-surface receptors co-operate for the initiation and expansion of immune responses. This research is providing clues on what is required from bacterial vaccines to be effective and is guiding the development and testing of new vaccine preparations in human and domestic animals.

A. Paulo G. Almeida is Associate Professor in Medical Entomology/ Parasitology, at the Institute of Hygiene and Tropical Medicine, Universidade Nova de Lisboa (IHMT/UNL), since 2009, where he is Director of the Unit of Medical Parasitology. He is currently a visiting professor at the ZRU, University of Pretoria. He has a Medical degree from the Classic University of Lisbon; Diploma in Tropical Medicine & Hygiene (DTM&H), Royal College of Physicians, London; MSc Medical Parasitology, University of London (LSHTM) and PhD in Medical Entomology/Parasitology, University of London (ICSTM). Researcher and teacher in Medical Entomology and Parasitology and Coordinator of the MSc in Medical Parasitology of the IHMT/UNL. Has been invited as teacher in University of Oporto, University of Algarve, Faculdade Ciências e Tecnologia/ UNL, Faculdade de Veterinária/ UTL, Instituto de Ciências Sociais e Políticas/ UTL and Faculdade de Ciências/ UL. APG Almeida is author/co-author of over 30 peer reviewed publications and 5 book chapters.

APG Almeida's main areas of interest are anti-vector (mosquito and tick) vaccines and immunity and Vector-Parasite relationships; Studies on mosquito vectors aimed at malaria, arboviruses (WNV, dengue), filariasis, vector incrimination, and epidemiology; Mosquito systematics, molecular biology, bioecological and surveillance and control studies in different ecological settings; Climate change and risk analysis of mosquito borne diseases, in collaboration with specialists on remote detection. Almeida has led various research projects in those areas, supervised several postgraduate degrees, and acted as a consultant for the Portuguese National Directorate of Health and ECDC.

Dr. Bogdan Circiumaru currently hold the position of a Consultant in Infectious Diseases at the „Matei Balş“National Institute of Infectious Diseases, in Bucharest, Romania. Qualified in 1989 at the Bucharest State University of Medicine, He obtained a Diploma in Tropical Medicine and Hygiene, and a Master of Science in Infectious Diseases from the University of London. This was followed by a PhD at the Bucharest State University of Medicine. He is an experienced clinician, with good skills in clinical infectious diseases and tropical pathology. His experience includes work under the supervision of Prof. Jon Cohen and David Mabey (London), and I also worked under the supervision of Prof. Antonella D`Arminio Monforte (Milan) with HIV/AIDS patients. He had numerous publications, especially in the infectious and Tropical Diseases. He had been awarded by the University of Bucharest with The Diploma of Excellence for the Book “Compendium of Infectious Diseases“. He also published a paper into the book: “NBC Risks (1999). Current Capabilities and Future Perspectives for Protection. NATO Science Series”.

Dr Atmaram Bandivdekar completed Ph D Degree at the age of 31 years from Mumbai University. He was Post-Doctoral and Carrier fellow at Population Council, New York. He was also the visiting scientist at UC Davis Primate Center, USA. He is the Consultant at National Institute for Research in Reproductive Health which is the premier Institute in India in the field of Reproductive Health Research. He has published more than 85 papers in peer reviewed journals and also the book and two conference proceedings. He also has six National and International awards for his scientific contributions.

Reproductive Biology, Endocrinology, Biochemistry, Virology and Immunology

Director of Infectious Diseases Unit at "Annunziata" Hospital, Cosenza, Italy

HIV infection & STDs, Bacterial and Fungal Infections,Antibiotics and Antifungal therapy.

Pei-Yong Shi, PhD, is I.H. Kempner Professor of Human Genetics, University of Texas Medical Branch, Galveston Texas, USA. He is also adjunct Professor of Emerging Infectious Diseases at the Duke-NUS Graduate Medical School in Singapore and Honorary Professor at the Wuhan Institute of Virology, Chinese Academy of Sciences. He received his Ph.D. in virology in 1996 from Georgia State University. After postdoctoral training at Yale University, he joined Bristol-Myers Squibb as a Principal Scientist to develop HIV and HCV therapeutics from 1998 to 2000. He then moved to the Wadsworth Center, New York State Department of Health, to study West Nile virus. From 2008 to 2015, he served as Dengue Unit Head and Executive Director to lead drug discovery at Novartis Institute for Tropical Diseases. His group developed the first infectious clone of the epidemic strain of West Nile virus, discovered two RNA cap methylation activities of flavivirus NS5 protein, identified essential RNA elements for flavivirus replication, established various platforms for flavivirus vaccine and drug discovery, and pioneered therapeutics development for dengue virus. He has published over 190 peer-reviewed articles and served as Editor (ACS Infectious Diseases, Journal of General Virology, and Nature Vaccine) and Editorial Board member (Journal of Virology, Virology, and Antiviral Research). He is internationally recognized for his scholar and administrative accomplishments at leading research institution, public health sector, and pharmaceutical industry.

Flaviviral infection, Human Diseases, Drug disovery and vaccines for Viral Infections

He has held important positions in academics (JN Medical college, Aligarh; AIIMS, New Delhi; Sharjah Medical College and Mahatma Gandhi Medical University, Jaipur); industrial research (Ranbaxy New Drug Discovery and Fortis Clinical Research Ltd) Diagnostic labs (Religare SRL Diagnostics and Star Metropolis); tertiary care hospital (JN Medical College, AIIMS and Medanta the Medicity) Public Health (CAREC, PAHO/WHO), Public Health Technology Transfer of PHFI. He has published over 100 research papers in peer reviewed international journals, guided over 40 students for their MD/MS/PhD and is named in 30 international patents. He is also the author of NBT sponsored book published by Churchill Livingstone, Antimicrobials in Laboratory Medicine (2000), Has contributed more than a dozen chapters in different books

Medical Microbiology

Associate Director of Clinical Proteomics Core Dept. of Pathology and Laboratory Medicine University of California Health System USA

Disease Biomarkers for Studies on Tuberculosis (TB)

Jintao Li, female, Professor, Director and Principle Investigator, Institute of Tropical Medicine, Third Military Medical University(TMMU). She got her master degree in molecular biology from Biotechnology Centre, Southwest University in 1996 and then became a faculty in Genetics Department, TMMU and got her Ph.D degree in Immunology Institute, PLA, TMMU in 2000 and became associate professor and then professor later since then till to 2013. From 2011-2012, she worked in Canada as a visiting scientist for one year. Now she has published more than 100 academic papers such as Science Translational Medicine, J.I, E.J.I, etc. and got 5 items of awards. Awards and group menberships 2010 Chongqing Natural Science Prize “Antigen immune response regulation” 2009 First class of Chinese medical award “Antigen protein antigenic properties and Engineering Research” 2005 Chongqing natural science prize “Relationship with the immune response to a protein antigen characteristic” 2003 Excellent graduate doctor in TMMU 1993~1996 University first grade Scholarship 1989~1993 University second grade Scholarship

Tropical Pathogens and Epidemiology, Immunology, Biotechnology & Molecular Biology

M Khalid Ijaz received DVM, MSc (Honors) from University of Agriculture, Faisalabad, Pakistan and completed Ph.D. in Microbiology and Immunology in 1985 at University of Ottawa, Canada. He did his post-doctoral work at the Vaccines and Infectious Disease Organization (VIDO), Canada. Currently, he’s Research Fellow at RB, Montvale, N.J. and Adjunct Associate Professor at The City University of New York (CUNY). His research focuses on human pathogenic microbial agents’ spread via the environment and mitigational role of hygiene agents. He is an active member of various scientific organizations including American Society for Microbiology, American Society for Virology, ASTM-International, Association of Professionals for Infection Control and Epidemiology and International Society for Infectious Diseases.

Human pathogenic microbial agents

Irina Magdalena Dumitru is an MD, PhD, Associate Professor, "Ovidius" University, Constanta, Romania, Faculty of Medicine. Senior Specialist in Infectious Diseases at Clinical Infectious Diseases Hospital, Constanta. Director of research and development (2006 – 2010) at Clinical Infectious Diseases Hospital, Constanta, in present I am Director of Research Department at Ovidius" University” Constanta. In recent years I am focused on the parasitological, tropical diseases, chronic hepatitis and HIV/AIDS research. In present I am NCP Health Romania for Horizon 2020 program. I am involved in many research projects, clinical trials and I have published numerous scientific articles (more than 95 papers and chapters in medical science journals and books). I am president of the Romanian Association of Parasitology, Constanta and I am member of many scientific societies (EACS, IAS, BENA, Romanian Association of Infectious Diseases, Romanian Association of Study Liver, Romanian Society of Microbiology).

Tropical infectious diseases

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Amr Ismail is an MBBCh, MSc, MD, MACP, FISQua, FABAM, CHPI, Consultant Dermatologist, received his Doctorate of Dermatology in 1998, Faculty of Medicine, Cairo University, Egypt, Fellow of the American Board of Aesthetic Medicine (ABAM), USA, Fellow of International Society for Quality in Healthcare (ISQua), Ireland, Certified Professional Health Performance Improvement, AIHQ, USA, Member of American College of Health Executives (ACHE), USA and Member of American College of Physicians (ACP).

Vaccines for HFMD

Ashok Kapse is a consulting Pediatrician practicing in the city of Surat in the Gujarat state of India, besides owning a private pediatric hospital he is also Head of the Pediatric Department at a prestigious Mahavir Super Specialty Hospital. After finishing graduation (MBBS) he did MD in Pediatrics. Initially he has worked as a Professor of Pediatrics at Medical College Surat, later he opted out for private practice however pursued academic interest. He developed special interest and skill in infectious diseases. He is a recipient of many oration awards and delivered hundreds of lectures on dengue, malaria, typhoid and antibiotic uses across India. He has decorated many a posts in medical fields: President of Surat City Branch of Indian Academy of Pediatrics (IAP), President of Gujarat State Branch of IAP and National President of Infectious Diseases Branch of IAP are few of them. He is an avid Clinical Photographer; his photos figure into various books and atlases including the prestigious atlas of infectious diseases published by American Academy of Pediatrics. He has published umpteen articles in peer reviewed journals.

Pediatric infectious diseases

Thomas D Licker has a BS in Environmental Science from Slippery Rock University and has over 20-years experience in handling event driven hazardous materials and biological response actions. He holds an accredited certification as a Council Certified Environmental Infection Control Remediator recognized by the Council for Engineering and Scientific Boards. He is the Director of Infection Control Technologies, a premier bioremediation services company and serves as the Director of Operations for Decontamination Professionals International.

Infection control technologies

Francis J Castellino is the Kleiderer-Pezold Professor of Biochemistry and Director of the WM Keck Center for Transgene Research at the University of Notre Dame, USA. He has coauthored more that 400 peer reviewed manuscripts.

Hemostasis system

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Rachel Groppo has completed her PhD in the laboratory of Dr. Ann Palmenberg at the University of Wisconsin, USA. After completing her Post doctorate at the University of Massachusetts Medical School, she has joined Sanofi Pasteur. Currently she is a Virology Manager at Sanofi Pasteur North American Research.

Virology

Eugenie Bergogne-Berezin is a Professor of Clinical Microbiology at University Diderot, Paris. She has studied MD in Medicine and PhD in Sciences in the early 1970s. She is a Chief of Department of Clinical Microbiology and research group, University Bichat Claude-Bernard and developed research on Acinetobacter spp., (nosocomial pathogen, pathogenicity, resistance), pharmacology of antibiotics, tissue distribution (lungs, brain, bronchi), research on intestinal ecology, jejunal flora and bacterial adhesion. She is an Adviser to pharmaceutical companies, expert in pharmacology-toxicology for the Ministry of Health, expert for international journals. She has developed a journal Antibiotics, (Elsevier). She has published 6 medical books, many chapters in international infectious diseases books, 200 articles in scientific journals.

Antibiotics

Fernanda De Freitas Anibal had her PhD from University of São Paulo, Brazil in Basic and Applied Immunology. She is a Principal Investigator at Laboratory of Parasitology (Federal University of São Carlos) seeks new tools for the treatment, prevention and diagnostics for infectious diseases. Currently, they are working with two plants and six enzymes and their effects against schistosomiasis mansoni and toxocariasis, about the treatment of the infectious diseases, their group studies effects of plants (extracts) and their isolated fractions in order to evaluate the anti-parasitic and anti-inflammatory effects and for infectious disease prevention, moreover have been working on the evaluation of the proteins of the parasite that has been potential to induce immune responses that decrease the parasite burden.

Immune responses

Joanna Zajkowska is currently working at Medical University of Białystok, Poland and carries Clinical Research on infectious diseases, especially on tick-borne diseases and nervous system diseases. She is an expert in internal medicine, infectious diseases, public health and epidemiology. She is a Member of ISW-TBE, Wien Austria (International Scientific Working group on Tick-Borne Encephalitis and ESGBOR (ESCMID-European Society of Clinical Microbiology and Infectious Diseases). She has published more than 200 papers in reputed journals and serving as a Reviewer in many journals.

Tick-borne diseases and nervous system diseases

Ashok Kapse is a consulting Pediatrician practicing in the city of Surat in the Gujarat state of India, besides owning a private pediatric hospital he is also Head of the Pediatric Department at a prestigious Mahavir Super Specialty Hospital. After finishing graduation (MBBS) he did MD in Pediatrics. Initially he has worked as a Professor of Pediatrics at Medical College Surat, later he opted out for private practice however pursued academic interest. He developed special interest and skill in infectious diseases. He is a recipient of many oration awards and delivered hundreds of lectures on dengue, malaria, typhoid and antibiotic uses across India. He has decorated many a posts in medical fields: President of Surat City Branch of Indian Academy of Pediatrics (IAP), President of Gujarat State Branch of IAP and National President of Infectious Diseases Branch of IAP are few of them. He is an avid Clinical Photographer; his photos figure into various books and atlases including the prestigious atlas of infectious diseases published by American Academy of Pediatrics. He has published umpteen articles in peer reviewed journals.

Pediatric infectious diseases

Stephen Mortlock X is the Global Infectious Diseases and Microbiology Liaison at the Q2 Solutions Laboratory in UK. Prior to joining Q2 Solutions, he was the Chief Microbiologist at the Shaukat Khanum Memorial Cancer Hospital and Research Centre in Lahore, Pakistan and was awarded a DSc for his work setting up an antenatal screening program for the indigent population. He with his colleagues has published over 40 papers on an eclectic mix of subjects from enteric pathogens, food science and saliva cotinine. He has also worked for the Health Protection Agency in the UK and spent time in the Middle East.

Global infectious diseases and microbiology

Junie Lia Monica is an MD, Ph D, Professor, Head Microbiology Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Romania. She is a Coordinator of resident doctor’s in the Laboratory Medicine specialty and Leadership PhD doctor’s thesis in Medicine field. She is a Board Member of European professional Societies ESCMID (ESGCP Study Groups), Society of Chemotherapy, Scientia Parasitologica Pro Vita and is a Reviewer of international reviews, Member of International organizations, Director/Coordinator in research projects. She has more than 63 papers published in full in international journals and is an editorial board member of national reviews. She is an Organizer/President, Keynote, Invited Speaker and Chair of International and National Congresses.

Microbiology

Maria Luisa G Daroy is a Scientist at the Research and Biotechnology Division of St. Luke’s Medical Center and Assistant Professor in the MS Molecular Medicine Program of the St. Luke’s College of Medicine-WHQ Memorial. She has published more than 20 papers on dengue, Japanese encephalitis, chikungunya, eye infections, dementia, diabetes and coronary artery disease. She was the Chair of the Board of Examiners of the Philippine Academy for Microbiology from 2013-2015 and authored a book chapter on Philippine microbiology research. Researches include dengue, chikungunya, diarrhea, CNS infections, pathogen genomics, antimicrobial resistance, plant antivirals, molecular diagnostics and genetics of CVD, thyroid cancer and dementia.

Dengue, chikungunya, diarrhea , CNS infections, pathogen genomics, antimicrobial resistance, plant antivirals, molecular diagnostics, genetics of CVD, thyroid cancer and dementia

Maria Del Rosario Davalos Gamboa has acquired her Pharmaceutical Biochemistry degree from the University of San Simon. She has started working at the University of San Simon in the Faculty of Medicine at the Laboratory of Nuclear Medicine and later from August 1992 continued working as a Teaching Research Assistant till 1998. From 2009 to 2010, she was the Director of the Research Institute of the Faculty of Dentistry UMSS and in 1997 won a competency exam at the Faculty of Dentistry UMSS in Biochemistry and appointed as a Professor. She is currently a Legal Representative and owner partner (in a greater proportion than 51% of shares) of the International Associated Factory oils and coals SRL ACECAB, in the city of Santa Cruz, Bolivia, whose principal activity is to generate cosmetic oils and charcoal.

Cancer research

Hiroshi Kida, DVM, PhD, Member of the Japan Academy, is Professor Emeritus, Head of the Research Center for Zoonosis Control at Hokkaido University, Sapporo, Japan, Head of the OIE Reference Laboratory for Avian Influenza, and Head of the WHO Collaborating Centre for Zoonoses Control. He has experiences of the development of influenza and leptospirosis vaccines as Research Officer at Takeda Chemical Industries, Ltd (1969-1976). Since 1976, he has devoted himself to research and education at Hokkaido University and been the recipient of several awards and honors such as Japan Academy Prize for “Studies on Control of Influenza -Mechanism of Emergence of Pandemic Influenza Virus Strains in Poultry, Domestic Animals and Humans, and Molecular Basis of the Neutralization of Viral Infectivity with Antibodies”. He is the author of 304 original articles and 142 book chapters and reviews.

His research interest includes ecology and pathogenesis of influenza viruses, zoonoses control, and vaccinology.

Dr. Webster received his BSc and MSc in Microbiology from Otago University in New Zealand. In 1962, he earned his PhD from the Australian National University and spent the next two years as a Fullbright Scholar working on influenza in the Department of Epidemiology at the University of Michigan, Ann Arbor.He is the Rose Marie Thomas Chair of the Virology Division, Department of Infectious Diseases, St. Jude Children's Research Hospital, Director, WHO Collaborating Center on the Ecology of Influenza Viruses in Lower Animals and Birds. Robert G. Webster is Professor in the Division of Virology, Department of Infectious Diseases at St. Jude Children's Research Hospital, and Director of the World Health Organization Collaborating Center for Studies on the Ecology of Influenza in Animals and Birds.His curriculum vitae contains over 480 original articles and reviews on influenza viruses. He has trained many scientists who now contribute to our understanding of the evolution and pathogenesis of influenza.

His interests include the emergence and control of influenza viruses, viral immunology, the structure and function of influenza virus proteins, and the development of new vaccines and antivirals. The major focus of his research is the importance of influenza viruses in wild aquatic birds as a major reservoir of influenza viruses and their role in the evolution of new pandemic strains for human and lower animals.

David Jackson is a Senior Principal Research Fellow with the National Health & Medical Research Council of Australia, a Professor in The University of Melbourne and a Chief Investigator of an NH&MRC Program Grant. In 2014 he was appointed Distinguished Professor in Hokkaido University, Japan.He has trained more than 50 graduate, postgraduate, doctoral and postdoctoral scholars and published more than 200 original research papers, invited reviews and book chapters in immunology, chemistry, biochemistry and vaccinology. He was one of the founders of the Cooperative Research Centre for Vaccine Technology and is senior inventor of a number of patents with licenses issued to the pharmaceutical industry. One of his inventions resulted in a first-in-man clinical trial of a synthetic epitope-based vaccine against hepatitis C virus. He is co-founder of 2 start-up biotechnology companies both of which are based on his own inventions. In the last five years his work has attracted more than twenty million dollars in research grants from nationally and internationally competitive sources, industry and investors.

David Jackson has been an active researcher in immunology and immunochemistry over the last 40 years. His research efforts are now focused on the design, assembly and evaluation of innovative vaccines which have led to pre-clinical and clinical evaluation of vaccine candidates for influenza, hepatitis C virus, Group A streptococcus, Mycobacterium tuberculosis and human papilloma virus. He has also developed candidate vaccines against methamphetamine and cocaine and against the reproductive hormone luteinizing hormone releasing hormone.

Lorena Brown is a professor at the University of Melbourne and at Hokkaido University. She is a lecturer in Virology to students of Science and Medicine and also heads a laboratory dedicated to understanding and controlling influenza.

Her work is focused on researching and evaluating new vaccines designed to combat both seasonal and highly lethal avian strains of influenza, including vaccines that induce cross-reactive T cell responses. As well as having a combined expertise in immunology and basic virology, her teamed is skilled in molecular virology techniques, which are used to understand the detailed replication of influenza virus and disease pathogenesis.

Indira T Kudva is a Research Microbiologist and Lead Scientist at the National Animal Disease Center, USDA, Ames, Iowa. She has received her BSc in Zoology and MSc in Medical Microbiology degrees from India, PhD in Microbiology, Molecular Biology and Biochemistry from the University of Idaho and trained as a Postdoctoral Fellow at the University of Idaho, Massachusetts General Hospital and Harvard Medical School. She has over 25 years of experience in the field of microbiology, molecular biology and infectious diseases. She has 29 peer-reviewed publications, 3 invited reviews, 27 meeting abstracts, 18 invited talks, 8 funded grants and novel inventions (4 patent applications). She is also an adjunct Assistant Professor at the School of Veterinary Medicine, Iowa State University; the Executive Editor for the “Virulence Mechanisms of Bacterial Pathogens” book, 5th Edition, ASM press and is on the Editorial Boards of the Applied and Environmental Microbiology (ASM press) and the SRL Proteomics and Bioinformatics (SciRes Literature) journals.

STEC interactions and factors

Amrita Dosanjh is a Pediatric Pulmonologist in San Diego and a member of several editorial boards. She completed her training at Harvard, CHOP and UCSD School of Medicine. Her studies have included investigations of respiratory viruses using cellular and molecular techniques.

Respiratory diseases

Fernanda De Freitas Anibal had her PhD from University of São Paulo, Brazil in Basic and Applied Immunology. She is a Principal Investigator at Laboratory of Parasitology (Federal University of São Carlos) seeks new tools for the treatment, prevention and diagnostics for infectious diseases. Currently, they are working with two plants and six enzymes and their effects against schistosomiasis mansoni and toxocariasis, about the treatment of the infectious diseases, their group studies effects of plants (extracts) and their isolated fractions in order to evaluate the anti-parasitic and anti-inflammatory effects and for infectious disease prevention, moreover have been working on the evaluation of the proteins of the parasite that has been potential to induce immune responses that decrease the parasite burden.

Immune responses

Maria Paula Ramalho Bajanca-Lavado has completed her PhD in Biomedical Science, specialty Microbiology and is responsible for the Haemophilus influenzae Reference Laboratory, Department of Infectious Diseases, National Institute of Health in Lisbon, Portugal. She has published several scientific publications in peer-review journals, along with other scientific productions, including invited lectures, oral communications and posters presented in international conferences. Her research is focused at H. influenzae infections, in different clinical and epidemiological aspects.

H. influenzae infections

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the Reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (medical) consequence management both in a military and a civilian (terrorism) setting. In his civil career he works internationally as a Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine.

Ebola

Elias Tannous is an infection control professional with more than 20 years experience in the healthcare setting. He holds degree in Nursing from the French Ministry of Health and from Saint Joseph University in Lebanon, degrees in Business Administrations and Human Resource/Personnel Management from UK and Certified Board in Infection Control, USA since 2008. He has coordinated, co-directed and facilitated loads of IC educational activities and has been heavily involved in major infection control activities, projects and programs for the past 10 years, including commissioning of new facilities, developing surveillance programs and evaluating IC programs.

Infection control

Naim Deniz Ayaz is an Associate Professor of the Department of Food Hygiene and Technology at Kirikkale University, Faculty of Veterinary Medicine. He has received his PhD in Food Hygiene and Technology from the Ankara University in 2008. He is the Vice Dean and Executive Board Member of Kirikkale University, Faculty of Veterinary Medicine; an Expert of the Biosafety Clearing-House Mechanism of Turkey; a Research and Advisory Board Member of the National Red Meat Council and an Editorial Board Member of several scientific journals. His main research interests are food microbiology, characterization of food-borne pathogens, bacteriophages, biocontrol of pathogens and bacterial antibiotic resistance.

Food microbiology

Aziz Alami Chentoufi is a Consultant and Head of Immunology/Serology/HLA section at Pathology and Clinical Laboratory Medicine, King Fahad Medical City (KFMC). He is also an Assistant Professor of Immunology at Faculty of Medicine, King Saud Ibn AbdulAziz University. He is the Chairperson of Research Committee of PCLMA-KFMC. He is the Diplomate of the American Board of Medical laboratory Immunology D(ABMLI ), Fellow of the Association of Clinical Sciences (FACSc), accredited by the European Society of Translational Medicine (PCTM) and Fellow of the Academy of translational Medicine (FacadTM). He received his Ph.D. in Biomedical Sciences (Tolerance induction to xenogenic and allogenic antigens using monoclonal antibody anti-igM and anti-IgD) from the University Catholic of Louvain, Brussels, Belgium in 1999. He has done postdoctoral fellowship at McGill University, Montreal, Canada from 1999 to 2004 where he worked on immunogenetic of type 1 Diabetes and gene therapy for graft versus host disease then he was appointed as specialist at the University of California Irvine-Medical Center, Irvine, California, USA in 2006 where he was a key investigator in the development of mucosal vaccine against herpes simplex virus type 1 and 2. He is an independent Immunologist with a national and international reputation in vaccine development against both infectious and autoimmune diseases. He is well-integrated into the scientific community within the United States as well as Europe and Saudi Arabia and he is actively involved in a number of professional societies including American Society of Histocompatibility and Immunogenetic (ASHI), Association of Clinical Scientist, Canadian Society of Immunology and The Federation of Clinical Immunology Societies (FOCIS). He is PI and Co-PI in a number of research grant proposals and associate editor in many scientific journals and has more than 50 publications in high impact factor journals.

Cellular and molecular immunology

Junie Lia Monica is an MD, Ph D, Professor, Head Microbiology Department, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj Napoca, Romania. She is a Coordinator of resident doctor’s in the Laboratory Medicine specialty and Leadership PhD doctor’s thesis in Medicine field. She is a Board Member of European professional Societies ESCMID (ESGCP Study Groups), Society of Chemotherapy, Scientia Parasitologica Pro Vita and is a Reviewer of international reviews, Member of International organizations, Director/Coordinator in research projects. She has more than 63 papers published in full in international journals and is an editorial board member of national reviews. She is an Organizer/President, Keynote, Invited Speaker and Chair of International and National Congresses.

Microbiology

Thomas D Licker has a BS in Environmental Science from Slippery Rock University and has over 20-years experience in handling event driven hazardous materials and biological response actions. He holds an accredited certification as a Council Certified Environmental Infection Control Remediator recognized by the Council for Engineering and Scientific Boards. He is the Director of Infection Control Technologies, a premier bioremediation services company and serves as the Director of Operations for Decontamination Professionals International.

Infection control technologies

Francis J Castellino is the Kleiderer-Pezold Professor of Biochemistry and Director of the WM Keck Center for Transgene Research at the University of Notre Dame, USA. He has coauthored more that 400 peer reviewed manuscripts.

Hemostasis system

Stef Stienstra is a strategic and creative Consultant in Biomedical Science with a parallel career as a Commander of the reserve of the Royal Dutch Navy. For the Dutch Armed Forces he has responsibility for the counter measures in CBNRe threats and (Medical) consequence management both in a military and a civilian (terrorism) setting. He is a strategic functional specialist for “Health & Environment” of the 1-Civil-Military-Interaction Command (1-CMI) of the Dutch Armed Forces and for 2015 also in the NATO Response Force (NRF), which is in 2015 the responsibility of the 1-German-Netherlands-Corps (1-GNC). In his civil career he works internationally as Consultant or as Scientific Supervisory Board Member for several medical and biotech companies, merely involved in biodefense. He is also a Visiting Professor for Punjab University in Pakistan and Rhein-Waal University in Germany. He has completed his studies in Medicine and in Biochemistry at the University of Groningen in The Netherlands and has extensive practical experience in cell biology, immuno-hematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

Ebola

Rachel Groppo has completed her PhD in the laboratory of Dr. Ann Palmenberg at the University of Wisconsin, USA. After completing her Post doctorate at the University of Massachusetts Medical School, she has joined Sanofi Pasteur. Currently she is a Virology Manager at Sanofi Pasteur North American Research.

Virology

Eugenie Bergogne-Berezin is a Professor of Clinical Microbiology at University Diderot, Paris. She has studied MD in Medicine and PhD in Sciences in the early 1970s. She is a Chief of Department of Clinical Microbiology and research group, University Bichat Claude-Bernard and developed research on Acinetobacter spp., (nosocomial pathogen, pathogenicity, resistance), pharmacology of antibiotics, tissue distribution (lungs, brain, bronchi), research on intestinal ecology, jejunal flora and bacterial adhesion. She is an Adviser to pharmaceutical companies, expert in pharmacology-toxicology for the Ministry of Health, expert for international journals. She has developed a journal Antibiotics, (Elsevier). She has published 6 medical books, many chapters in international infectious diseases books, 200 articles in scientific journals.

Antibiotics

Joanna Zajkowska is currently working at Medical University of Białystok, Poland and carries Clinical Research on infectious diseases, especially on tick-borne diseases and nervous system diseases. She is an expert in internal medicine, infectious diseases, public health and epidemiology. She is a Member of ISW-TBE, Wien Austria (International Scientific Working group on Tick-Borne Encephalitis and ESGBOR (ESCMID-European Society of Clinical Microbiology and Infectious Diseases). She has published more than 200 papers in reputed journals and serving as a Reviewer in many journals.

Tick-borne diseases and nervous system diseases

Ashok Kapse is a consulting Pediatrician practicing in the city of Surat in the Gujarat state of India, besides owning a private pediatric hospital he is also Head of the Pediatric Department at a prestigious Mahavir Super Specialty Hospital. After finishing graduation (MBBS) he did MD in Pediatrics. Initially he has worked as a Professor of Pediatrics at Medical College Surat, later he opted out for private practice however pursued academic interest. He developed special interest and skill in infectious diseases. He is a recipient of many oration awards and delivered hundreds of lectures on dengue, malaria, typhoid and antibiotic uses across India. He has decorated many a posts in medical fields: President of Surat City Branch of Indian Academy of Pediatrics (IAP), President of Gujarat State Branch of IAP and National President of Infectious Diseases Branch of IAP are few of them. He is an avid Clinical Photographer; his photos figure into various books and atlases including the prestigious atlas of infectious diseases published by American Academy of Pediatrics. He has published umpteen articles in peer reviewed journals.

Pediatric infectious diseases

Maria Luisa G Daroy is a Scientist at the Research and Biotechnology Division of St. Luke’s Medical Center and Assistant Professor in the MS Molecular Medicine Program of the St. Luke’s College of Medicine-WHQ Memorial. She has published more than 20 papers on dengue, Japanese encephalitis, chikungunya, eye infections, dementia, diabetes and coronary artery disease. She was the Chair of the Board of Examiners of the Philippine Academy for Microbiology from 2013-2015 and authored a book chapter on Philippine microbiology research. Researches include dengue, chikungunya, diarrhea, CNS infections, pathogen genomics, antimicrobial resistance, plant antivirals, molecular diagnostics and genetics of CVD, thyroid cancer and dementia.

Dengue, chikungunya, diarrhea , CNS infections, pathogen genomics, antimicrobial resistance, plant antivirals, molecular diagnostics, genetics of CVD, thyroid cancer and dementia

Maria Del Rosario Davalos Gamboa has acquired her Pharmaceutical Biochemistry degree from the University of San Simon. She has started working at the University of San Simon in the Faculty of Medicine at the Laboratory of Nuclear Medicine and later from August 1992 continued working as a Teaching Research Assistant till 1998. From 2009 to 2010, she was the Director of the Research Institute of the Faculty of Dentistry UMSS and in 1997 won a competency exam at the Faculty of Dentistry UMSS in Biochemistry and appointed as a Professor. She is currently a Legal Representative and owner partner (in a greater proportion than 51% of shares) of the International Associated Factory oils and coals SRL ACECAB, in the city of Santa Cruz, Bolivia, whose principal activity is to generate cosmetic oils and charcoal.

Cancer research

Ines Garcia-Garcia completed her medical training at the University of Puerto Rico. She is Board Cetified in Pediatrics Specialty and in the Neonatal-Perinatal Medicine Subspecilaty. She is a Professor at the University of Puerto Rico, School of Medicine. She has published in reputed journals and books, including articles related to intrauterine exposure to viral infections and congenital anomalies. She actively participates in graduate medical education programs. She is member of national and international research and academic associations. Dr. García has participated as a speaker in multiple professional meetings in the Unided States, Latin-America and Europe.

Preemies and Families

Dr. Mandy Hill has acquired a wealth of academic experience in the design, development, and implementation of behavioral research within a clinical setting. Trained as a clinical researcher, Dr. Hill has a documented history of advancing a prevention-based public health agenda within a clinical environment. Her academic portfolio to date has been based on creating a niche of merging public health and emergency medicine. She has published 22 peer reviewed manuscripts, 10 of which she first authored, in diverse areas addressing health disparities among disadvantaged minority populations, coupled with 25 abstracts, 20 presentations and extramural funding support from the Center for Disease Control and Prevention and the National Institutes of Health through the American Psychological Association and Centers for AIDS Research, as well as industry sponsored research. These tangible outcomes attest to her scientific contributions to date. Her primary research focus is HIV/AIDS, STIs, and STDs. In summary, here expertise includes the design, implementation, and analysis of pilot and exploratory studies, randomized clinical trial development and implementation, and integrating public health-based prevention research into routine clinical visits in the emergency department.

HIV/AIDS, STIs, and STDs

Marc H V Van Regenmortel is currently an Emeritus Research Director at the CNRS (French National Research Center) in the School of Biotechnology of the University of Strasbourg, France. He was for 22 years Director of the Immunochemistry Laboratory at the CNRS Molecular Biology Institute in Strasbourg and previously was a professor at several universities in South Africa and France. He served (1984-1990) as Vice Chairman and Chairman of the Virology Division of the International Union of Microbiological Societies (IUMS) and was Secretary General of IUMS from 1990 to 1999. He was also for six years (1996-2002) President of the International Committee on Taxonomy of Viruses. He supervised the research work of 30 PhD students and has published 400 research and review papers as well as 17 books in the fields of Virology and Immunochemistry. In 2009 he co-edited with Brian Mahy of the CDC in Atlanta, the third edition of the Encyclopedia of Virology in 5 volumes published by Elsevier. He is currently Editor-in-Chief of Archives of Virology, Journal of Molecular Recognition and Journal of AIDS & Clinical Research; An Associate Editor of Advances in Virus Research, Frontiers in Immunotherapies and Vaccines, Journal of Immunological Methods, ISRN Immunology and Bionomina.

General virology, Immunochemistry of viruses, viral diagnostics, synthetic peptide vaccines, HIV vaccines, SPR biosensors, viral taxonomy, philosophy of science

Dr. Kimberly A. Parker is an Associate Professor at Texas Womans University in Denton, TX. She has earned a PhD from the University of Georgias College of Public Health, a MPH from the Arnold School of Public Health at the University of South Carolina, and is a Master Certified Health Education Specialist. Dr. Parker conducts qualitative and mixed-methods research on women and minority health issues and currently serves as the Principle Investigator for several research projects. Her primary studies are Be-PrEPared, a curriclum development project to assess the implementation of a multi-strategies intervention to increase knowledge and awareness about PrEP among cis- and trans-women of color, Lend Us Your Voice Project, a qualitative study which examines the lived experience of HIV positive African American women in the South, and the HIV risk assessment study which examines multiple variables associated with contracting HIV, social vulnerabilities, and HIV risk perceptions among African American women. She has also spearheaded several public health curriculum design and evaluation projects related to HIV prevention and womens health issues. Dr. Parker has written several manuscripts on HIV/AIDS, the intersection of race and gender, and minority health issues, and has served as a guest columnist for the Dallas Morning News and The Body. Her research interest includes social sexual factors that influence HIV transmission and health disparities among vulnerable populations.

.

Dr Stef Stienstra is a Strategic and creative development manager in biomedical science, with a parallel career as a reserve commander of the Royal Dutch Navy. For the Dutch Armed Forces he has a responsibility in the counter measures in CBNRe threats and consequence management both in a military and in a civilian (terrorism) context. In his civil career he works internationally as consultant or as scientific supervisory board member for several medical and biotech companies. At this moment for MT-Derm in Berlin (D) developing a novel intradermal vaccination technology, IQ Therapeutics in Groningen (NL) developing therapeutic antibodies against anthrax and orthopox viruses, Hemacon in Düsseldorf (D) developing a field donor blood separation and blood transfusion unit, Infection Control in Eemnes (NL) developing a bio-disinfection system for bioterrorism consequence management and IB Consulting in The Hague (NL) for biodefense projects. He has finished his studies Medicine and Biochemistry in The Netherlands and has extensive practical experience in cell biology, immuno-haematology, biodefense and transfusion medicine. His natural business acumen and negotiation competence helps to initiate new successful businesses, often created out of unexpected combinations of technologies. His good understanding of abstract science combined with excellent skills in the communication of scientific matters to non-specialists, helps him with strategic consulting at top level management.

CBRN defense, (therapeutic) vaccines, trauma healthcare, blood transfusion, sailing

Timms is Professor of Microbiology and Director of Research at QUT’s Institute of Health and Biomedical Innovation in Brisbane Australia. He is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections. Timms has published over 170 refereed journal papers and is editor of the journal, Pathogens and Disease.

He leads a well established research team of 10 people. His research group is developing vaccines and new diagnostics for chlamydial diseases in humans and animals as well as an improved understanding of chlamydial genomics, cell biology and pathogenicity. The group is widely acknowledged for its major contributions to chlamydial infections in koalas and other wildlife, including the development of a vaccine for koalas.

Kevin Galalae is the world’s foremost independent authority on the globalization-depopulation axis around which the international system has revolved since the inception of the United Nations in 1945, and the first to expose and scientifically demonstrate the existence, methods and consequences of the Global Depopulation Policy. He is the founder and Director of the Center of Global Consciousness (CGC), which is dedicated to the eradication of all covert chemical, biological, psychosocial and economic methods of population control and to their replacement with overt population control legislation through a global replacement level fertility law.

covert chemical, biological and bacteriological methods, Causes and Consequences of the Global Depopulation Policy and Chemical and Biological Depopulation.

Enric Pedrol is from Fundació Sant Hospital Infectious Diseases, Internal Medicine (General Medicine), Spain

Infectious Disease, Medicine, HIV, Infection, AIDS, Hepatitis C, Liver, Hepatitis Viruses